Ensnarement — A 2nd Bite At The Noninfringement Apple

By Brian D. Coggio and Ron Vogel (August 15, 2018, 1:32 PM EDT) -- "Ensnarement" is a potent defense to a finding of infringement under the doctrine of equivalents. Indeed, on July 30, 2018, in Janssen Biotech Inc. v. Celltrion Healthcare Co. Ltd., the U.S. District Court for the District of Massachusetts granted Celltrion's motion for summary judgment of noninfringement, holding that Janssen's proposed hypothetical claims covering the manufacture of Inflectra ensnared the prior art.

Ensnarement is based on the principle that the allowable range of equivalents to a patent claim cannot encompass or "ensnare" the prior art. To establish infringement under the doctrine of equivalents, the patentee — after a successful jury verdict —...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!